Abdominal aortic calcification in patients with inflammatory bowel disease: does anti-tumor necrosis factor α use

Aikaterini Mantaka1,2, Nikolaos Galanakis3, Dimitrios Tsetis1,3

  • 1Faculty of Medicine, University of Crete, Heraklion, Greece.

Intestinal Research
|August 5, 2022
PubMed

Insights

Over a third of inflammatory bowel disease (IBD) patients show moderate-severe abdominal aortic calcium (AAC) deposition. Anti-tumor necrosis factor-alpha (TNF-α) therapy may protect against atherosclerosis in IBD patients.

Area of Science:

  • Cardiovascular Medicine
  • Gastroenterology
  • Radiology

Background:

  • Abdominal aortic calcium (AAC) is a marker for early atherosclerosis.
  • No prior studies evaluated AAC in inflammatory bowel disease (IBD).

Purpose of the Study:

  • To evaluate AAC deposition in IBD patients.
  • To correlate AAC with IBD characteristics and cardiovascular disease (CVD) risk factors.

Main Methods:

  • AAC quantified via CT or enterography in 98 IBD patients and matched controls.
  • Correlations assessed with IBD features, disease activity, labs, and CVD risk factors.

Main Results:

  • Moderate-severe AAC found in 35.7% of IBD patients vs. 30.6% of controls.
  • IBD with CVD and ulcerative colitis showed higher severe atherosclerotic lesions.
  • Extensive disease and lifetime steroid use were independent AAC risk factors in non-CVD IBD patients.
  • Anti-TNF-α use was negatively associated with AAC in non-CVD IBD patients.

Conclusions:

  • Over one-third of IBD patients exhibit moderate-severe AAC.
  • Anti-TNF-α agents may offer protection against AAC deposition and atherosclerosis in IBD.
Abstract

Related Concept Videos

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
223
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
367
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
401
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
68
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
112
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
29